// April 25, 2023 | 18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia

Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein